Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › LA › Winnsboro › NPI 1356399539
Hospital

Franklin Parish Hospital Service District No1

Franklin Parish Hospital Service District No1 was paid $12.61M by Medicaid between Jan 2018 and Dec 2024, across 160 billing codes. Its largest line is 99284, emergency room visit (serious) — 24% of everything it billed.

33Billing provider infoFRANKLIN PARISH HOSPITAL SERVICE DISTRICT NO1
WINNSBORO, LA 71295
33aNPI1356399539assigned 05/04/2006
33bProvider typeRural Acute Care Hospital
28Total paid$12.61M
24GClaims396,344
24DCodes billed160
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Rural Acute Care Hospital providers in Louisiana

Rank by total paid#4 of 8
Median peer was paid$12.38M
This provider vs. median1.0×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201843,192$950K
201946,856$842K
202042,249$889K
202160,963$1.98M
202268,200$2.59M
202377,269$3.15M
2024incomplete57,615$2.20M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 24% 12,566 10,881 $3.04M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 17% 7,099 5,964 $2.16M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 13% 10,841 9,649 $1.67M
0202U Oncology (prostate), multianalyte, gene expression profiling 4.9% 1,813 1,638 $618K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 3.3% 6,509 4,815 $417K
96361 Intravenous infusion, hydration; each additional hour 2.8% 7,478 4,634 $352K
96375 Therapeutic injection; each additional sequential IV push 2.6% 7,674 5,501 $330K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 2.2% 7,257 5,562 $280K
80050 General health panel 2.1% 7,353 6,480 $270K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 1.9% 3,968 3,074 $245K
71045 Radiologic examination, chest; single view 1.8% 6,882 5,696 $230K
80053 Comprehensive metabolic panel 1.6% 27,805 23,142 $203K
148 more codes
99213 Doctor's office visit, returning patient (routine) 1.4% 5,331 $173K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 1.2% 4,768 $153K
94762 1.2% 3,434 $148K
36415 Collection of venous blood by venipuncture 1.1% 69,011 $141K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 1.1% 8,244 $139K
80061 Lipid panel <1% 10,301 $118K
70450 Computed tomography, head or brain; without contrast material <1% 969 $108K
85027 <1% 18,172 $99K
84443 Thyroid stimulating hormone (TSH) <1% 5,789 $94K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 1,326 $91K
84439 <1% 11,830 $89K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 16,832 $83K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 1,037 $77K
20610 <1% 1,158 $73K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 2,077 $70K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 2,074 $70K
73523 <1% 505 $69K
83036 Hemoglobin; glycosylated (A1C) <1% 7,756 $56K
G0378 Hospital observation service, per hour <1% 274 $55K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 2,651 $52K
J7030 Infusion, normal saline solution , 1000 cc <1% 5,689 $47K
74177 Computed tomography, abdomen and pelvis; with contrast material <1% 119 $46K
81001 <1% 19,723 $42K
99214 Doctor's office visit, returning patient (more involved) <1% 867 $41K
84484 <1% 6,821 $36K
72100 <1% 754 $36K
83735 <1% 8,581 $31K
82728 <1% 2,945 $31K
80305 <1% 3,219 $29K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 940 $26K
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 1,052 $26K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 907 $21K
71046 Radiologic examination, chest; 2 views <1% 504 $20K
83550 <1% 2,953 $20K
72040 <1% 401 $19K
73562 <1% 413 $18K
73522 <1% 302 $17K
81025 <1% 2,271 $15K
83880 <1% 1,021 $15K
83540 <1% 3,038 $15K
84481 <1% 1,446 $15K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 34 $15K
82607 <1% 1,146 $14K
84480 <1% 1,942 $14K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 150 $14K
73564 <1% 259 $11K
82746 <1% 934 $11K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 236 $10K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 106 $10K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 3,177 $8K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 1,970 $8K
83605 <1% 1,279 $7K
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg <1% 895 $6K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 121 $6K
85730 <1% 2,017 $5K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 226 $5K
87486 <1% 2,012 $5K
87086 Culture, bacterial; quantitative colony count, urine <1% 836 $5K
87581 <1% 1,979 $5K
73130 <1% 102 $5K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 524 $5K
83690 <1% 1,111 $5K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 1,844 $4K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 2,101 $4K
85610 <1% 2,234 $4K
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 39 $4K
82670 <1% 160 $4K
82553 <1% 1,055 $4K
82550 <1% 1,143 $4K
80048 Basic metabolic panel (calcium, ionized) <1% 771 $4K
82077 <1% 289 $3K
84403 <1% 154 $3K
77078 <1% 68 $3K
J7120 Ringers lactate infusion, up to 1000 cc <1% 1,059 $3K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 109 $3K
J2270 Injection, morphine sulfate, up to 10 mg <1% 999 $3K
73030 <1% 58 $3K
83001 <1% 157 $3K
72052 <1% 70 $3K
73110 <1% 43 $2K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 13 $2K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 164 $2K
99203 Doctor's office visit, new patient (routine) <1% 80 $2K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 798 $2K
72125 Computed tomography, cervical spine; without contrast material <1% 14 $2K
77067 Screening mammography, bilateral, including computer-aided detection <1% 16 $2K
72110 <1% 40 $2K
74018 <1% 45 $1K
96367 <1% 38 $1K
84550 <1% 388 $1K
85651 <1% 388 $1K
82962 <1% 684 $1K
86140 <1% 302 $1K
J3475 Injection, magnesium sulfate, per 500 mg <1% 97 $1K
94761 <1% 108 $1K
51798 <1% 324 $973.66
86225 <1% 78 $926.34
73610 <1% 18 $882.13
82150 <1% 197 $838.87
M0239 Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring <1% 43 $832.29
83970 <1% 27 $784.32
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 13 $778.07
87040 <1% 151 $741.47
74022 <1% 14 $730.07
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 51 $701.76
86038 <1% 66 $694.20
82948 <1% 265 $677.09
73565 <1% 19 $641.68
82043 <1% 122 $554.23
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 1,285 $537.54
72050 <1% 13 $531.62
80143 <1% 35 $466.00
80179 <1% 34 $447.36
J2550 Injection, promethazine hcl, up to 50 mg <1% 175 $424.49
84153 <1% 26 $405.57
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 176 $395.36
85379 <1% 52 $376.66
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 30 $371.66
82570 <1% 96 $368.11
86431 <1% 72 $359.59
86376 <1% 25 $334.65
96376 <1% 119 $334.53
84630 <1% 40 $330.31
J0780 Injection, prochlorperazine, up to 10 mg <1% 48 $329.98
87210 <1% 60 $325.36
87070 <1% 52 $285.48
S0119 Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) <1% 12 $285.02
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 15 $264.88
81003 <1% 290 $258.66
84466 <1% 29 $229.68
86141 <1% 16 $194.25
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 19 $174.92
87807 <1% 14 $173.16
J7050 Infusion, normal saline solution, 250 cc <1% 33 $162.40
J2704 Injection, propofol, 10 mg <1% 837 $93.20
J0690 Injection, cefazolin sodium, 500 mg <1% 206 $65.57
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 12 $32.90
J3490 Unclassified drugs <1% 74 $26.95
J3010 Injection, fentanyl citrate, 0.1 mg <1% 174 $21.00
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 47 $8.02
J2274 Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg <1% 13 $6.02
86901 <1% 35 $3.32
86900 <1% 35 $3.32
G0463 Hospital outpatient clinic visit for assessment and management of a patient 0% 648 $0.00
90853 Group psychotherapy (other than of a multiple-family group) 0% 8,706 $0.00
J1956 Injection, levofloxacin, 250 mg 0% 35 $0.00
Q0243 Injection, casirivimab and imdevimab, 2400 mg 0% 15 $0.00
T1015 A visit at a community health center or clinic (one all-in rate) 0% 19 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialKRAMER, MICHAEL (ADMINISTRATOR)
Same official

Other billing entities under KRAMER, MICHAEL

Full network →
ProviderLocationPaid
Mercy Health - West Hospital LLCCincinnati, OH$45.57M
Franklin Parish Hospital Service District No1Winnsboro, LA$29.39M
Franklin Parish Hospital Service District No1Winnsboro, LA$2.59M
Franklin Parish Hospital Service District No1Newellton, LA$2.49M
Franklin Parish Hospital Service District No1Winnsboro, LA$1.53M
Franklin Parish Hospital Service District No1Saint Joseph, LA$1.30M
Franklin Parish Hospital Service Dist 1Gilbert, LA$426K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.